ADPT News and Press, Adaptive Biotechnologies Corporation From 12/27/23

SEATTLE, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating...

2023-12-15 01:19:38 ET Summary Adaptive Biotechnologies' MRD segment, primarily clonoSEQ, shows growth (24% revenue increase) amid sector challenges. ADPT faces an overall financial decline (21% revenue drop, larger net loss), reflecting broader biotech industry pressures. Sho...

2023-12-12 20:24:54 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value increased slightly to $24.64B, with 80 holdings. The largest positions in the portfolio are Visa, Workday, Amazon.com, United Parcel Service, and Danaher Corp. New stakes include Block Inc., Freep...

2023-12-12 05:50:00 ET Innovations often come from less-known places. Cathie Wood fully realizes this. While her Ark Invest exchange-traded funds (ETFs) hold positions in many of the most widely followed stocks in the world, she also focuses heavily on identifying diamonds in the rough that...

Treatment adapted studies show the potential for MRD assessment to guide the personalization of blood cancer care New data demonstrates MRD assessed from blood in multiple myeloma may be an indicator of early response SEATTLE, Dec. 09, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechno...

SEATTLE, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, together with its collaborators will pre...

2023-11-22 23:31:20 ET Summary ARK Genomic Revolution ETF focuses on genomic innovation in sectors such as healthcare, information technology, and energy. The fund's buying and selling activity gives us clues about the degrees of conviction relative to its main holdings. The f...

2023-11-10 10:00:06 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employ...

2023-11-09 22:01:03 ET Adaptive Biotechnologies Corporation (ADPT) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Karina Calzadilla - Head, IR Chad Robins - CEO and Co-founder Tycho Peterson - CFO Nitin Sood - Chief Commerci...

2023-11-09 16:32:23 ET More on Adaptive Biotechnologies Adaptive Biotechnologies: Not Quite There Yet, Growth Looks Priced Adaptive Biotechnologies Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Adaptive Biotechnologies Historical earnings da...